Skip to main content

Ampio Pharmaceuticals, Inc. (AMPE)

NYSEAMERICAN: AMPE · IEX Real-Time Price · USD
1.70 -0.10 (-5.56%)
Sep 20, 2021 10:57 AM EDT - Market open
Market Cap360.82M
Revenue (ttm)n/a
Net Income (ttm)-15.21M
Shares Out196.18M
EPS (ttm)-0.08
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume675,287
Open1.72
Previous Close1.80
Day's Range1.69 - 1.77
52-Week Range0.72 - 2.98
Beta1.77
AnalystsBuy
Price Target4.00 (+135.3%)
Est. Earnings DateNov 3, 2021

About AMPE

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunology-based therapies for the treatment of prevalent inflammatory conditions in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-016, an intravenous treatment that is in Phase I/II clinical trial for COVID-19 patients with respiratory illness; and AP-014, an inhaled treatment that is in Phase I clinical trial for COVID-19 induce...

IndustryPharmaceuticals
CEOMichael Macaluso
Employees18
Stock ExchangeNYSEAMERICAN
Ticker SymbolAMPE
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for AMPE stock is "Buy" and the 12-month stock price forecast is 4.00.

Price Target
$4.00
(135.29% upside)
Analyst Consensus: Buy

News

Best Penny Stocks For Retail Traders to Buy? 3 For Your List

Investing in penny stocks right now? Check these three small caps out for your watchlist The post Best Penny Stocks For Retail Traders to Buy?

Other symbols:SHIPWTRH
3 days ago - PennyStocks

Penny Stocks For Your Biotech Watch List In September 2021

Penny stocks that may be worth watching right now. The post Penny Stocks For Your Biotech Watch List In September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:CASICFMSCLVSEYEG
5 days ago - PennyStocks

Ampio Pharmaceuticals Announces Top-line Results from AP-013 Phase III Study of Ampion in Adult Patients Suffering fr...

ENGLEWOOD, Colo., Sept. 15, 2021 /PRNewswire/ --  Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflamma...

5 days ago - PRNewsWire

Ampio Pharmaceuticals Announces Important New Research Manuscript on Anti-Inflammatory Mode of Action

ENGLEWOOD, Colo., Aug. 13, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent infl...

1 month ago - PRNewsWire

Ampio Pharmaceuticals Reminds Stockholders to Vote Shares in Advance of 2021 Annual Meeting

ENGLEWOOD, Colo., Aug. 12, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent infl...

1 month ago - PRNewsWire

Ampio Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences

ENGLEWOOD, Colo., Aug. 11, 2021 /PRNewswire/ --  Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inf...

1 month ago - PRNewsWire

Why Penny Stocks Investors Are Bullish on These 3 Small-Caps

Why penny stocks investors are showing bullish interest in these 3 small-caps The post Why Penny Stocks Investors Are Bullish on These 3 Small-Caps appeared first on Penny Stocks to Buy, Picks, News and...

Other symbols:CIDMSOS
1 month ago - PennyStocks

Here's Why Ampio Pharmaceuticals Stock Is Surging Today

A positive second-quarter earnings report and anticipation of further details to be discussed this afternoon helped this beaten-down biotech stock recover some previous losses.

1 month ago - The Motley Fool

Ampio Pharmaceuticals, Inc. Announces Second Quarter 2021 Financial Results and Provides Corporate Update

ENGLEWOOD, Colo., Aug. 4, 2021 /PRNewswire/ --  Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent infl...

1 month ago - PRNewsWire

Ampio Pharmaceuticals to Present at the American College of Toxicology 42nd Annual Meeting

ENGLEWOOD, Colo., July 29, 2021  /PRNewswire/ -- Ampio Pharmaceuticals  (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflamma...

1 month ago - PRNewsWire

Ampio Pharmaceuticals to Present at the 14th International Congress on Systemic Lupus Erythematosus (LUPUS 2021) & 6t...

ENGLEWOOD, Colo., July 28, 2021 /PRNewswire/ --  Ampio Pharmaceuticals  (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflamma...

1 month ago - PRNewsWire

Ampio Pharmaceuticals to Present at Aspen Lung Conference

ENGLEWOOD, Colo., July 27, 2021 /PRNewswire/ --  Ampio Pharmaceuticals  (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflamma...

1 month ago - PRNewsWire

Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 Second Quarter Financial Results and Provide Corporate Business Update

ENGLEWOOD, Colo., July 14, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammato...

2 months ago - PRNewsWire

Best Biotech Penny Stocks In Summer 2021? 7 For Your Watchlist

Are these the best biotech penny stocks to watch right now? The post Best Biotech Penny Stocks In Summer 2021?

Other symbols:ACSTADMPBIOLJAGXNWBO
2 months ago - PennyStocks

Ampio's Phase 2 Study Of Inhaled Ampion In COVID-19 Patients Gets Underway

Ampio Pharmaceuticals, Inc. (NYSE: AMPE) announced an update to its COVID-19 program that is evaluating its lead asset Ampion. What Happened: Colorado-based Ampio announced the commencement of randomiza...

2 months ago - Benzinga

Ampio Pharmaceuticals Announces Patient Randomization and Dosing in AP-019 Phase II Study of Inhaled Ampion in COVID-...

ENGLEWOOD, Colo., June 25, 2021 /PRNewswire/ --  Ampio Pharmaceuticals  (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflamma...

2 months ago - PRNewsWire

Ampio Pharmaceuticals, Inc. to Join the Russell 2000® Index and Russell 3000® Index

ENGLEWOOD, Colo., June 18, 2021 /PRNewswire/ – Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for preval...

3 months ago - PRNewsWire

Ampio Provides Update on Osteoarthritis of the Knee (OAK) Program, Reiterates Compelling Data in Earlier Phase III Tr...

ENGLEWOOD, Colo., June 17, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammato...

3 months ago - PRNewsWire

Hot Penny Stocks to Buy? 3 to Watch As Vaccine Rates Hit New Highs

Best penny stocks to watch with vaccine rates higher than ever The post Hot Penny Stocks to Buy? 3 to Watch As Vaccine Rates Hit New Highs appeared first on Penny Stocks to Buy, Picks, News and Informat...

Other symbols:CEIMUX
3 months ago - PennyStocks

Ampio Pharmaceuticals Receives Approval to Expand Enrollment of its AP-019 Phase II Study to India

ENGLEWOOD, Colo., June 15, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammato...

3 months ago - PRNewsWire

Ampio Pharmaceuticals to Present at the 2021 International Society for Pharmaceutical Engineers Annual Meeting and Expo

ENGLEWOOD, Colo., June 14, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for preva...

3 months ago - PRNewsWire

Ampio Pharmaceuticals to Participate in the Alliance Global Partners' Virtual Summer Healthcare Symposium

ENGLEWOOD, Colo., June 11, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for preva...

3 months ago - PRNewsWire

Ampio Pharmaceuticals to Present Poster at the International Society for Aerosols in Medicine (ISAM) 23rd Internation...

ENGLEWOOD, Colo., May 21, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for preval...

3 months ago - PRNewsWire

Ampio Pharmaceuticals Receives Investigational Review Board Approval for its Phase I Long COVID-19 Trial (AP-018)

ENGLEWOOD, Colo., May 10, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammator...

4 months ago - PRNewsWire

Ampio Pharmaceuticals, Inc. Reports First Quarter 2021 Financial Results and Provides Business Update

ENGLEWOOD, Colo., May 5, 2021 /PRNewswire/ --  Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammator...

4 months ago - PRNewsWire